Nalaganje...

Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis

Monoclonal antibodies (Mabs) are a favorite drug platform of the biopharmaceutical industry. Currently, over 20 Mabs have been approved and several hundred others are in clinical trials. The anti-LINGO-1 Mab Li33 was selected from a large panel of antibodies by Fab phage display technology based on...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pepinsky, R Blake, Silvian, Laura, Berkowitz, Steven A, Farrington, Graham, Lugovskoy, Alexey, Walus, Lee, Eldredge, John, Capili, Allan, Mi, Sha, Graff, Christilyn, Garber, Ellen
Format: Artigo
Jezik:Inglês
Izdano: Wiley Subscription Services, Inc., A Wiley Company 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868238/
https://ncbi.nlm.nih.gov/pubmed/20198683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pro.372
Oznake: Označite
Brez oznak, prvi označite!